Biomea Fusion is trading 10.42% up at $1.85, versus the August 31, 2026 close of $1.68, with no new company-specific announcement dated September 1, 2026 identified to explain the gain.

  • Biotechnology stocks are down 4.24%; the Nasdaq and S&P 500 are also lower amid geopolitical, inflation, and interest-rate concerns.
  • The August 24 enrollment-completion announcement previously drove a major rally but does not establish today’s catalyst.